BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 15803820)

  • 1. Subclavian vein stenosis following totally implantable venous access device (TIVAD) implant by percutaneous approach. Case report.
    Di Carlo I; Fasone MA; Toro A; Castello G; Sparatore F; Cordio S
    G Chir; 2004; 25(11-12):417-9. PubMed ID: 15803820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN; Roland D; Cade A
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombosis and stenosis of central venous access in hemodialysis].
    Vanherweghem JL
    Nephrologie; 1994; 15(2):117-21. PubMed ID: 8047195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Encapsulated implantable venous access device: two clinical cases].
    Guivarch E; Kriegel I; Bonnet L; di Maria S; Estève M
    Ann Fr Anesth Reanim; 2009 Mar; 28(3):238-41. PubMed ID: 19327941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Totally implantable venous access systems. Analysis of complications].
    D'Angelo F; Ramacciato G; Caramitti A; Aurello P; Lauro S; Bordin F; Della Casa U
    Minerva Chir; 1997; 52(7-8):937-42. PubMed ID: 9411296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External jugular vein cutdown approach, as a useful alternative, supports the choice of the cephalic vein for totally implantable access device placement.
    Di Carlo I; Barbagallo F; Toro A; Sofia M; Lombardo R; Cordio S
    Ann Surg Oncol; 2005 Jul; 12(7):570-3. PubMed ID: 15889215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications.
    Di Carlo I; Pulvirenti E; Mannino M; Toro A
    Ann Surg Oncol; 2010 Jun; 17(6):1649-56. PubMed ID: 20204533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decompression of the occluded subclavian vein in the patient with ipsilateral threatened access by transposition of the internal jugular vein.
    Gertler JP
    ASAIO J; 1995; 41(4):896-8. PubMed ID: 8589473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of approach for totally implantable venous access device decreases rate of complications.
    Karanlik H; Kurul S
    J Surg Oncol; 2009 Sep; 100(3):279-83. PubMed ID: 19582820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Learning curve and early complications of totally implantable venous access devices: is tutoring the solution for the problem?].
    Di Carlo I; Toro A; Sofia M; Fasone MA; Barbagallo F; Russello D
    G Chir; 2004 Apr; 25(4):146-8. PubMed ID: 15283408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclavian vein stenosis: complication of subclavian vein catheterization for hemodialysis.
    Lee SJ; Neiberger R
    Child Nephrol Urol; 1991; 11(4):212-4. PubMed ID: 1777904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-assisted percutaneous catheterization of the axillary vein for totally implantable venous access device.
    Lin CP; Wang YC; Lin FS; Huang CH; Sun WZ
    Eur J Surg Oncol; 2011 May; 37(5):448-51. PubMed ID: 21345637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Totally implantable venous access devices: The supraclavicular percutaneous approach and early complications.
    Bai XM; Wang J; Zhou Y; Sun XW; Cheng L; Gu XS; Yuan Q; Jing J; Zhang J; Gu LY; Jin Y
    J Cancer Res Ther; 2020; 16(7):1575-1581. PubMed ID: 33565502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospective study of thromboses of the subclavian vein after setting implantable venous access systems in cervico-facial cancerology].
    Bonfils P; Luciani JA; Potard G; Bassot V
    Ann Otolaryngol Chir Cervicofac; 1996; 113(7-8):425-9. PubMed ID: 9207977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forty years after the first totally implantable venous access device (TIVAD) implant: the pure surgical cut-down technique only avoids immediate complications that can be fatal.
    Toro A; Schembari E; Fontana EG; Di Saverio S; Di Carlo I
    Langenbecks Arch Surg; 2021 Sep; 406(6):1739-1749. PubMed ID: 34109472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central vein stenosis: a nephrologist's perspective.
    Agarwal AK; Patel BM; Haddad NJ
    Semin Dial; 2007; 20(1):53-62. PubMed ID: 17244123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central vein obstruction in vascular access.
    Mickley V
    Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):439-44. PubMed ID: 16765068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alternative technique for totally implantable central venous access devices. A retrospective study of 1311 cases.
    Chang HM; Hsieh CB; Hsieh HF; Chen TW; Chen CJ; Chan DC; Yu JC; Liu YC; Shen KL
    Eur J Surg Oncol; 2006 Feb; 32(1):90-3. PubMed ID: 16289481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy.
    Kim JT; Oh TY; Chang WH; Jeong YK
    Med Oncol; 2012 Jun; 29(2):1361-4. PubMed ID: 21380779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.